Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Cash from Discontinued Operations: 2023-2024

Historic Cash from Discontinued Operations for Mimedx Group (MDXG) over the last 2 years, with Dec 2024 value amounting to $1,000.

  • Mimedx Group's Cash from Discontinued Operations fell 99.90% to $1,000 in Q4 2024 from the same period last year, while for Dec 2024 it was -$930,000, marking a year-over-year increase of 88.61%. This contributed to the annual value of -$930,000 for FY2024, which is 88.61% up from last year.
  • Per Mimedx Group's latest filing, its Cash from Discontinued Operations stood at $1,000 for Q4 2024, which was up 200.00% from -$1,000 recorded in Q3 2024.
  • Mimedx Group's 5-year Cash from Discontinued Operations high stood at $987,000 for Q4 2023, and its period low was -$4.6 million during Q1 2023.
  • Moreover, its 2-year median value for Cash from Discontinued Operations was -$216,000 (2023), whereas its average is -$1.1 million.
  • Examining YoY changes over the last 5 years, Mimedx Group's Cash from Discontinued Operations showed a top increase of 99.68% in 2024 and a maximum decrease of 99.90% in 2024.
  • Mimedx Group's Cash from Discontinued Operations (Quarterly) stood at $987,000 in 2023, then tumbled by 99.90% to $1,000 in 2024.
  • Its Cash from Discontinued Operations was $1,000 in Q4 2024, compared to -$1,000 in Q3 2024 and -$123,000 in Q2 2024.